1e
19
1
49
2
2
18
1b
1d
18
33
4a
1d
2 29
1d
25
Mark H. Schutta, M.D.
78
4a
G. Clayton Kyle Professor in Diabetes
28
76
3
5f
Attending Physician, Hospital of the University of Pennsylvania
89
Member, Institute for Diabetes, Obesity and Metabolism, University of Pennsylvania
64
Director of Diabetes Strategy, Penn Medicine
77
Medical Director, Institute for Diabetes, Obesity and Metabolism
11
Department: Medicine
4
1
b
1d
46
Contact information
4c
4
3
3
3
2
29
4
b
1f
4c
Penn Rodebaugh Diabetes Center
1d 4th Floor, Penn Tower
32 Hospital of the University of Pennsylvania
3a 3400 Spruce Street
Philadelphia, PA 19104-4283
26
1d 4th Floor, Penn Tower
32 Hospital of the University of Pennsylvania
3a 3400 Spruce Street
Philadelphia, PA 19104-4283
2e
Office: 215-662-2468
32 Fax: 215-349-8529
24
f
32 Fax: 215-349-8529
24
13
Education:
21 9 B.A. 1e (Political Science) c
45 University of Wisconsin-Madison, Madison, WI, 1984.
21 9 M.D. c
56 Thomas Jefferson University Medical College, Philadelphia, PA, 1993.
c
3
3
3
3
8b
Permanent link21 9 B.A. 1e (Political Science) c
45 University of Wisconsin-Madison, Madison, WI, 1984.
21 9 M.D. c
56 Thomas Jefferson University Medical College, Philadelphia, PA, 1993.
c
2 29
21
1e
1d
24
5e
65
1a 29
27
Description of Research Expertise
ea Dr. Schutta is involved in several research areas including the effects of bariatric surgery on diabetes remission and the association between coronary calcification and cardiovascular risk in type 2 diabetic patients.65
Description of Clinical Expertise
1c1 Dr. Schutta specializes in the diagnosis and treatment of diabetes and hypoglycemia disorders. Dr. Schutta predominantly cares for patients with pre-diabetes, type 1 and type 2 diabetes as well as post-transplantation diabetes. He has a particular interest in diabetes prevention and in-patient management of diabetes and hyperglycemia. Dr. Schutta presently serves as Medical Director of the Penn Rodebaugh Diabetes Center.1a 29
23
b0 Schutta MH.: Diabetes and Hypertension. Journal of Cardiometabolic Syndrome Page: 124-130, Spring 2007.
f9 Rickels MR., Schutta MH., Mueller R., Kapoor S., Markmann JF., Naji A., Teff KL.: Glycemic Thresholds for Activation of Counterregulatory Hormone and Symptom Responses in Islet Transplant Recipients 4a J Clin Endocrinol Metab 92(3): 873-9, March 2007.
de Cardillo S., Schutta MH.: Repaglinide Induced Hypoglycemia in a Patient with Cystic Fibrosis-Related Diabetes Mellitus. Endo Trends 13(4): 6-7, 2006.
fe Rickels MR., Schutta MH., Markmann JF., Barker CF., Naji A., Teff KL.: Beta-cell function following human islet transplantation for type 1 diabetes. Diabetes 54(1): 100-6, Jan 2005.
145 Rickels MR., Schutta MH., Markmann JF., Barker CF., Naji A., Teff KL.: Beta-Cell Function Following Human Islet Transplantation for Type 1 Diabetes Mellitus: Preliminary Results. Oral presentation at the American Diabetes Association Meeting June 2007.
12b Reilly MP., Iqbal N., Schutta M., Wolfe ML., Scally M., Localio AR., Rader DJ., Kimmel SE.: Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes. J Clin Endocrinol Metab 89(8): 3872-8, Aug 2004.
2c
7
1d
1f
Selected Publications
154 Martin SS., Qasim AN., Mehta NN., Wolfe M., Terembula K., Schwartz S., Iqbal N., Schutta M., Bagheri R., Reilly MP.: Apolipoprotein B but not LDL cholesterol is associated with coronary artery calcification in type 2 diabetic whites. Diabetes 58: 1887-1892, Dec 2009.b0 Schutta MH.: Diabetes and Hypertension. Journal of Cardiometabolic Syndrome Page: 124-130, Spring 2007.
f9 Rickels MR., Schutta MH., Mueller R., Kapoor S., Markmann JF., Naji A., Teff KL.: Glycemic Thresholds for Activation of Counterregulatory Hormone and Symptom Responses in Islet Transplant Recipients 4a J Clin Endocrinol Metab 92(3): 873-9, March 2007.
de Cardillo S., Schutta MH.: Repaglinide Induced Hypoglycemia in a Patient with Cystic Fibrosis-Related Diabetes Mellitus. Endo Trends 13(4): 6-7, 2006.
fe Rickels MR., Schutta MH., Markmann JF., Barker CF., Naji A., Teff KL.: Beta-cell function following human islet transplantation for type 1 diabetes. Diabetes 54(1): 100-6, Jan 2005.
145 Rickels MR., Schutta MH., Markmann JF., Barker CF., Naji A., Teff KL.: Beta-Cell Function Following Human Islet Transplantation for Type 1 Diabetes Mellitus: Preliminary Results. Oral presentation at the American Diabetes Association Meeting June 2007.
12b Reilly MP., Iqbal N., Schutta M., Wolfe ML., Scally M., Localio AR., Rader DJ., Kimmel SE.: Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes. J Clin Endocrinol Metab 89(8): 3872-8, Aug 2004.
2c